The US Food and Drug Administration (FDA) has tentatively approved Amneal Pharmaceuticals Inc.'s Abbreviated New Drug Application (ANDA) for beclomethasone dipropionate HFA inhalation aerosol (40 mcg/actuation and 80 mcg/actuation), according to the
FUJIFILM India has recently introduced its new healthcare technology, FW 500 Clinical Chemistry Analyzer, which consolidates In-vitro Diagnostics. The FW500 offers both the expertise in dry chemistry Fujifilm has developed over 40 years plus...
In an interaction with Thiruamuthan, Assistant Editor of India Pharma Outlook, Ankush Kapoor, Founder & CEO of PharmNXT Biotech, discusses how India’s biotech ecosystem is redefining bioprocessing through Single-Use Technologies, Defined Tubing Routi
Eli Lilly and Company and Walmart Inc. have announced a new collaboration aimed at improving access to affordable obesity treatments
Shilpa Medicare, a full-service CDMO (Contract Development and Manufacturing Organization), has launched its new Flow Chemistry Centre of Excellence (CoE) at its Bengaluru site in Dobbespet, Avarahalli Industrial Area...
The EU GMP certification has significantly enhanced the alignment of Indian pharmaceutical manufacturing facilities with global quality standards, according to Arpit Bhatia, director of Laborate Pharmaceuticals
US direct sales market leader Amway will pump in USD 12 million (approximately Rs 100 crore) in India in the next three to five years to augment retail reach and deepen distribution network. The decision is in line with Amway's increasing focus...
The U.S. Food and Drug Administration (FDA) has given approval to Lynkuet (elinzanetant), Bayer's dual neurokinin (NK) receptor antagonist that is not accompanied by the use of hormones
Salesforce India has introduced Agentforce Life Sciences for Customer Engagement, expanding its Agentforce Life Sciences portfolio with an innovative, agent-first solution designed to transform how life sciences organizations connect with healthcare
Eli Lilly announced on Tuesday that it is partnering with NVIDIA to create a supercomputer aimed at expediting drug discovery and reducing development timelines, thereby allowing the company to provide medications to patients more swiftly